Is AI replacing radiologists at KHCC?

No. The AI tools run as triage and prioritisation aids. Radiologists remain responsible for all diagnostic interpretation. The programme is designed to improve workflow efficiency and consistency across affiliated sites.

How does KHCC validate the AI tools?

Before deployment, KHCC runs internal validation using its own historical imaging data, comparing AI performance against expert radiologist readings. Post-deployment, performance is monitored continuously.

Does the AI handle Arabic-language radiology reports?

Current deployments generate findings in standard radiology terminology, with reports signed off by Arabic-proficient radiologists. Arabic-language clinical note summarisation is a future workload under exploration.

Are there other Jordanian hospitals using AI radiology?

Yes, though at smaller scale. The Royal Medical Services network and some private Amman hospitals have piloted AI radiology tools, typically at one or two sites.

Can regional oncology patients access KHCC's AI-enhanced services?

KHCC's international patient programme continues to serve patients from the Levant, Iraq, and North Africa. AI-enhanced workflows are applied consistently across all patients, regardless of country of origin.

King Hussein Cancer Center Is Rolling Out AI Radiology Across Amman, and Jordan Just Became a Regional Teaching Case

Amman's King Hussein Cancer Center has completed the first phase of a hospital-wide AI radiology deployment, covering breast imaging, chest CT, and brain MRI. The programme, in partnership with Aidoc and Lunit, now runs across 12 clinical sites in Greater Amman and is being expanded to KHCC-affiliated centres in Aqaba, Irbid, and Karak. Jordan's healthcare AI story rarely gets regional attention, but the KHCC programme is now the largest single oncology AI deployment in the MENA region.

Why KHCC's deployment is different

Most regional healthcare AI announcements are pilots, framed at the hospital director level. KHCC's programme is operational across every shift, reviewed daily by radiologists, and integrated into the clinical workflow. That is a genuinely different maturity tier.

KHCC has been a regional oncology centre of excellence for decades, drawing patients from across the Levant, Iraq, and North Africa. The AI deployment is positioned to extend that reach, letting affiliated sites in less-resourced areas run the same quality of triage and reporting as the Amman flagship.

By The Numbers

12 AI radiology deployed across 12 clinical sites in Greater Amman, with four affiliated centres in expansion.
5,500 KHCC handles over 5,500 new cancer cases annually and more than 150,000 imaging studies per year.
35% Reported radiology reporting turnaround improvement: approximately 35% on triaged cases.
94% Breast cancer detection sensitivity using the Lunit INSIGHT MMG tool measured at 94% in KHCC's internal validation.
6.4 million Programme investment to date: roughly JOD 6.4 million ($9 million) over three years.

We are not using AI to replace radiologists. We are using it to let our radiologists do the hardest work faster, and to lift the quality baseline across affiliated sites.
Dr. Asem Mansour, CEO, King Hussein Cancer Center

King Hussein Cancer Center Is Rolling Out AI Radiology Across Amman, and Jordan Just Became a Regional Teaching Case

What the AI stack actually does

Three workloads are running in production:

Breast imaging triage using Lunit INSIGHT MMG, flagging suspicious mammograms for expedited review.
Chest CT triage using Aidoc for pulmonary embolism and incidental nodule detection.
Brain MRI triage for intracranial haemorrhage and stroke, also through Aidoc.

Each workload feeds into a central radiology information system (RIS), with outputs presented as prioritisation flags rather than diagnostic statements. Radiologists remain the decision-making authority. The distinction is important both clinically and legally.

Regional oncology AI deployments

Centre	Country	Primary AI partner	Scope
King Hussein Cancer Center	Jordan	Aidoc, Lunit	Breast, chest, brain imaging
Cleveland Clinic Abu Dhabi	UAE	GE Edison, internal	Radiology, pathology
Hamad Medical Corporation	Qatar	Microsoft, Paige	Pathology, radiology
King Faisal Specialist Hospital	Saudi Arabia	Internal, Microsoft	Broad clinical AI
Sheikh Shakhbout Medical City	UAE	Mayo Clinic collaboration	Clinical decision support

KHCC's programme differentiates through scale of operational integration rather than breadth of tools. The Aidoc and Lunit deployments are being used on every relevant case, not a subset.

Jordan's strength is that KHCC has always practised above its country's average investment level. Taking AI mainstream in oncology is the natural next step.
Dr. Huda Omar, Advisor, Jordan Health Accreditation Council

The financing and sustainability question

KHCC is a non-profit, funded through a mix of government support, international donors, and patient fees. The AI programme has been co-funded by KHCC, the King Hussein Cancer Foundation, and international development support, including from World Bank MENA health programmes. That multi-source financing model has allowed KHCC to act faster than a purely public Jordanian hospital could have.

The sustainability question is real. AI radiology licences are recurring costs, and KHCC's funding model depends on keeping them within operational budgets. The centre has signalled intent to recoup AI costs through accelerated throughput, a pragmatic but untested theory in Jordanian cost accounting.

The AI in Arabia View: Jordan does not get the regional headlines. It does not have the budget of a Gulf peer, the population of Egypt, or the sovereign wealth of a Qatar. What it has is institutions that punch above their weight, and KHCC is the clearest example. Rolling AI radiology across every site, not a pilot, not a demo, is the kind of move that forces regional peers to ask harder questions about their own programmes. Expect KHCC's methodology, particularly the emphasis on workflow integration rather than tool count, to be studied by Gulf health systems considering similar deployments. The open question is funding continuity. Donor-funded AI infrastructure is politically unusual, and KHCC's model depends on maintaining both the institutional relationships and the international operational grants through 2030.